Although existing studies have preliminarily elucidated that Zhujieshen exerts anti-tumor effects through PI3K–Akt, PKCα–ERK1/2, and TLR4/NF-κB pathways, these pathways do not operate in isolation but constitute a dynamically interconnected regulatory network. The gene discussed is AKT1; the disease is neoplasm.